Repligen reported $3.22M in Interest Expense on Debt for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Interest Expense On Debt Change
Agilent A:US $ 21M 0M
Biomarin Pharmaceutical BMRN:US $ 3.87M 0.05M
Bristol Myers Squibb BMY:US $ 328M 2M
Catalent CTLT:US $ 26M 5.9M
Charles River Laboratories CRL:US $ 16.45M 0.26M
Danaher DHR:US $ 62M 0M
Dentsply International XRAY:US 13M 3M
Exact Sciences EXAS:US $ 4.68M 0.03M
Fluidigm FLDM:US 968K 72K
General Electric GE:US $ 203M 35M
Henry Schein HSIC:US $ 6.55M 0.17M
Illumina ILMN:US $ 14M 2M
IQVIA Holdings Inc IQV:US $ 92M 2M
Mettler Toledo International MTD:US 11.79M 1.35M
Myriad Genetics MYGN:US $ 1.1M 0.9M
Pacific Biosciences Of California PACB:US $ 3.67M 0.08M
Patterson Companies PDCO:US $ 5.52M 0.33M
Peregrine Pharmaceuticals PPHM:US 704K 1000
Perkinelmer PKI:US $ 43.53M 26.78M
Pfizer PFE:US $ 325M 9M
Repligen RGEN:US $ 3.22M 0.08M
Thermo Fisher Scientific TMO:US $ 128M 6M
Waters WAT:US $ 8.53M 3.49M
West Pharmaceutical Services WST:US $ 1.8M 0.1M